Arrotek will be attending New York Valves 2026, one of the leading events dedicated to structural heart innovation and transcatheter valve technologies.
The conference brings together clinicians, innovators, investors, and industry leaders working to advance the next generation of therapies for patients with valvular heart disease. As structural heart technologies continue to evolve, collaboration between device developers, engineering teams, and manufacturing partners remains critical to accelerating innovation and improving patient outcomes.
At Arrotek, we support medical device companies throughout the product development lifecycle, from concept development and design engineering through to verification, validation, and commercial manufacturing. With extensive experience in catheter technologies and minimally invasive medical devices, we work with customers to overcome complex technical challenges and bring innovative products to market efficiently.
Our team is looking forward to engaging with industry leaders, exploring emerging technologies, and discussing how integrated development and manufacturing expertise can help accelerate structural heart device programmes.
If you are attending New York Valves 2026 and would like to discuss your next development project, we would welcome the opportunity to connect.
For more information about Arrotek’s medical device development and manufacturing capabilities, contact our team on [email protected]
